Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia

Clinical trial NCT01515176 · COMPLETED

Trial details

NCT number

NCT01515176

Sponsor

National Cancer Institute (NCI)

Status

COMPLETED

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2012-01-01

Primary completion

2015-03-04

Enrollment

36

View on ClinicalTrials.gov